Skip to ContentSkip to Navigation
How to find us prof. dr. H.J. (Hiddo) Lambers Heerspink


A novel drug response score more accurately predicts renoprotective drug effects than existing renal risk scores

A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy

A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in Europe

Biochemical Urine Testing of Medication Adherence and Its Association With Clinical Markers in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT)

Blood Pressure Effects of Canagliflozin and Clinical Outcomes in Type 2 Diabetes and Chronic Kidney Disease: Insights from the CREDENCE Trial

Canagliflozin Reduces Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial

Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial

Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on potassium handling in patients with acute heart failure

Read more


Canagliflozin May Reduce Anemia Risk in Diabetic CKD

Geneesmiddel verlengt levensverwachting bij patiënten met nierfalen

Positief effect diabetesmedicatie op nierfunctie direct toepasbaar in klinische praktijk

Pil die nieren spaart bij suikerziekte

Diabetes type 1,2,3,4 en 5: op weg naar gepersonaliseerde behandeling

Intervieuw Diabetes Fonds Dialoog

De Route van hoogleraar Hiddo Lambers Heerspink

Read more